• Home
  • PTCKD OTTO Pharmaceuticals

PTCKD OTTO Pharmaceuticals

About PTCKD OTTO Pharmaceuticals

Established in 2015, PT CKD OTTO Pharmaceuticals (“CKD OTTO Pharma”) is a joint venture between Chong Kun Dang Pharm Corp., Korea, with PT Otto Pharmaceutical Industries, Indonesia. CKD OTTO Pharma specialization is anti-cancer drugs as known as oncology medicines in Indonesian market. We cooperate with many hospitals throughout Indonesia to provid...

Read more Show less
Certifications
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Indonesia
  • On CPHI since:
    2022
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
CMO/CDMO
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
Contact info
  • +62 21 2500513
  • Website
  • Mayapada 2 Building 8th Floor 4th Unit, Jenderal Sudirman Street Kav 27 Street, Kuningan, Karet Kuningan, Setiabudi, South Jakarta City, Jakarta 12920, 12920, South Jakarta, Jakarta, Indonesia
Show contact info Hide contact info

Products from PTCKD OTTO Pharmaceuticals (3)

  • Pemecine - Pemetrexed

    Product Pemecine - Pemetrexed

    Composition: Pemetrexed 100 mg & 500 mg

    Indication: The treatment of malignant pleural mesothelioma & non-small cell lung cancer

    Packed in : Dry vial 100 mg & 500 mg

  • Tezobell - Bortezomib

    Product Tezobell - Bortezomib

    Composition: Bortezomib 3.5 mg

    Indication: 
    The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy. 

    Packed in : Dry vial 3.5 mg
  • Belloxa - Oxaliplatin

    Product Belloxa - Oxaliplatin

    Composition Oxaliplatin 50 mg &100 mg

    Indication
    Adjuvant treatment of stage III colon cancer (Duke stage C) after complete resection of initial tumor, treatment of metastatic colorectal cancer